| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT01913483 Details | 2017-05-30 Interventional | 3 | 732 | Bivalirudin Calcium heparin Heparin Bleeding Peripheral Endo… | - - | |||
| NCT00808899 Details | 2017-05-30 Interventional | 2 | 4 | Cyclophosphamid… Doxorubicin Etoposide Irinotecan Isotretinoin Temsirolimus Topotecan Tretinoin Neuroblastoma | Voluntarily closed and terminated by the PI due to lack of feasibility NB2008 was closed because of the publication of a new standard of care for treating high-risk neuroblastoma.At the time of closure, NB2008 had enrolled only 4 patients, which was an insufficient number of patients to answer the primary objective. | |||
| NCT00242879 Details | 2017-05-30 Interventional | 2 | 130 | Ritonavir Acquired Immuno… Communicable Di… HIV Infections Infections HIV-1 Infection Infection, Huma… | - - | |||
| NCT00104429 Details | 2017-05-30 Interventional | 2 | - | Aplaviroc Lamivudine, zid… Acquired Immuno… Communicable Di… HIV Infections Infections HIV Infection Infection, Huma… | - - | |||
| NCT00102778 Details | 2017-05-30 Interventional | 2 | - | Aplaviroc Lopinavir Ritonavir Acquired Immuno… Communicable Di… HIV Infections Infections HIV Infection Infection, Huma… | - - | |||
| NCT00088881 Details | 2017-05-25 Interventional | 2 | 62 | Cyclophosphamid… Doxorubicin Liposomal doxor… Prednisone Rituximab Vincristine Lymphoma Lymphoma, B-Cel… Lymphoma, B-Cel… Lymphoma, Large… Lymphoma, Non-H… Waldenstrom Mac… Contiguous Stag… Extranodal Marg… Nodal Marginal … Noncontiguous S… Splenic Margina… Stage I Adult D… Testicular Lymp… Waldenström Ma… | - - | |||
| NCT01843738 NCT02042040 Details | 2017-05-24 Interventional | 1 | 0 | Vemurafenib Melanoma BRAFV600 Mutati… Stage IV Melano… | Competing Trials - | |||
| NCT01674413 Details | 2017-05-24 Interventional | 3 | 0 | Adalimumab Crohn Disease Crohn's Disease | Unable to recruit; all patients interested simply wanted to stop medication - | |||
| NCT00450983 Details | 2017-05-24 Interventional | 2 | 1 | Fludarabine Fludarabine pho… Methotrexate Muromonab-CD3 Thiotepa Graft vs Host D… Leukemia Myelodysplastic… Preleukemia Syndrome Graft Versus Ho… | - - | |||
| NCT00832624 Details | 2017-05-23 Interventional | 4 | 10 | Sitagliptin Pho… Diabetes Mellit… Diabetes Mellit… Diabetes Mellit… | Business Reasons The planned 18-week study was terminated early due to reconsideration of the study design. None of the 10 patients progressed beyond the second study visit, no laboratory tests were performed, and adverse experience data were not collected. | |||
| NCT02047019 2012-004493-26 Details | 2017-05-22 Interventional | 3 | 0 | Candesartan Candesartan cil… Nifedipine Essential Hyper… Hypertension | GPDC decided to terminate the study - | |||
| NCT01757574 Details | 2017-05-18 Interventional | 4 | 0 | Alemtuzumab Polyradiculoneu… Polyradiculoneu… Chronic Inflamm… | At the request of the global principal investigator, no subjects were enrolled in this study at
any site. - | |||
| NCT02200328 Details | 2017-05-17 Interventional | 4 | 76 | Metronidazole Clostridium Inf… Diarrhea Clostridium Dif… | Patients noncompliant with instructions and follow ups could not be completed. Early termination: Many patients did not comply with the protocol instructions. Lack of resources to conduct the study. Many patients did not respond to follow up calls. | |||
| NCT01542372 Details | 2017-05-17 Interventional | 4 | 114 | Prazosin Stress Disorder… Stress Disorder… Posttraumatic S… | Inadequate flow of patients Owing to lack of recruitment sites the study was ended early. In addition, many more patients than anticipated had no PTSD after Step I and hence could not be randomized to participate in Step II. This greatly impacted on flow. | |||
| NCT00947791 Details | 2017-05-17 Interventional | 4 | 1 | Ketamine Midazolam Bipolar Disorde… Depression | Change in available resources for study procedures - | |||
| NCT00599053 Details | 2017-05-17 Interventional | 1/2 | 7 | Azithromycin Birth Weight Communicable Di… Infections Respiratory Tra… Ureaplasma Infe… Bacteria Infect… | Enrollment was terminated early due to a change in practice on the obstetrical side that
included administering azithromycin to women with preterm labor. Early termination due to small number enrolled. | |||
| NCT03153072 Details | 2017-05-15 Interventional | 2 | 0 | Amiodarone Tachycardia Tachycardia, Su… Tachycardia, Ve… Supraventricula… | decision of the investigator - | |||
| NCT02289482 Details | 2017-05-15 Interventional | 1 | 20 | GSK-2838232 Ritonavir Acquired Immuno… HIV Infections Infection, Huma… | Study prematurely terminated due to safety concerns leading to clinical hold - | |||
| NCT02202304 Details | 2017-05-15 Interventional | 4 | 0 | Chlorhexidine Chlorhexidine g… Thymol Periodontal Dis… Caries Periodontal Dis… | Researcher changed jobs. Unable to carry out the project - | |||
| NCT01355302 2011-000774-58 Details | 2017-05-15 Interventional | 1/2 | 7 | Capecitabine Stomach Neoplas… Advanced or Met… Previously Untr… | Sites not recruiting The study was terminated prior to enrollment in Phase 2. |